CLINUVEL PHARMACEUTICALS

Clinuvel Pharmaceuticals Limited is a biopharmaceutical company. The Company is focused on developing drugs for the treatment of a range of severe skin disorders. Its lead compound, SCENESSE (afamelanotide 16 milligrams), prevents phototoxicity (anaphylactoid reactions and burns) in adult patients with erythropoietic protoporphyria (EPP). The Company focuses at preventing the symptoms of skin diseases related to the exposure to harmful ultra violet (UV) radiation and at repigmentation of the ski... n due to a number of depigmentation disorders. SCENESSE has completed Phase II and III trials in the United States and Europe, and has been granted marketing authorization by the European Commission for adults with EPP. It has operations in Europe, the United States and Singapore. SCENESSE acts by increasing the levels of melanin in the skin and shields against UV radiation (UVR) and sunlight. SCENESSE is delivered via a subcutaneous dissolving implant.
CLINUVEL PHARMACEUTICALS
Industry:
Biotechnology Developer Platform Pharmaceutical
Founded:
2001-01-01
Address:
Melbourne, Victoria, Australia
Country:
Australia
Website Url:
http://www.clinuvel.com
Total Employee:
11+
Status:
Active
Contact:
61 3 9660 4900
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome Domain Not Resolving Wordpress Plugins
Current Employees Featured
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2014-07-27 | Travere Therapeutics | Travere Therapeutics acquired by Clinuvel Pharmaceuticals | 95 M USD |
Official Site Inspections
http://www.clinuvel.com Semrush global rank: 2.39 M Semrush visits lastest month: 7.69 K
- Host name: 175.37.109.208.host.secureserver.net
- IP address: 208.109.37.175
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260

More informations about "Clinuvel Pharmaceuticals"
People - CLINUVEL
CLINUVEL Pharmaceuticals Ltd 2023 ANNUAL REPORT 48. Under Dr Wolgenโs leadership, a long-term strategy for CLINUVEL was devised. The lead product SCENESSE® โฆSee details»
About CLINUVEL
CLINUVEL excels in scientific research and development. We build on our global expertise to deliver long-term care and develop novel products for patients and consumers. The โฆSee details»
CLINUVEL PHARMACEUTICALS LTD - LinkedIn
CLINUVEL PHARMACEUTICALS LTD (ASX: CUV; NASDAQ INTERNATIONAL DESIGNATION ADR: CLVLY; XETRA-DAX: UR9) is a global and diversified biopharmaceutical company focused on developing and commercialising ...See details»
CLINUVEL Company Profile | Management and Employees List
CLINUVEL Profile and History. Founded in 1987, CLINUVEL is a global bio-pharmaceutical company that specializes in developing and commercializing treatments for patients with โฆSee details»
CLINUVEL, INC. Company Profile | Burlingame, CA | Competitors ...
Find company research, competitor information, contact details & financial data for CLINUVEL, INC. of Burlingame, CA. Get the latest business insights from Dun & Bradstreet.See details»
Clinuvel Pharmaceuticals - Crunchbase Company โฆ
Clinuvel Pharmaceuticals Limited is a biopharmaceutical company. The Company is focused on developing drugs for the treatment of a range of severe skin disorders. Its lead compound, SCENESSE (afamelanotide 16 milligrams), โฆSee details»
Clinuvel Pharmaceuticals - The Org
Clinuvel Pharmaceuticals is a global and diversified biopharmaceutical company focused on developing and commercialising treatments for patients with genetic, metabolic, and life-threatening disorders, as well as healthcare solutions for โฆSee details»
Clinuvel AG Company Profile | Baar, ZUG, Switzerland
Find company research, competitor information, contact details & financial data for Clinuvel AG of Baar, ZUG. Get the latest business insights from Dun & Bradstreet.See details»
Clinuvel Pharmaceuticals Ltd - EverybodyWiki Bios & Wiki
Clinuvel Pharmaceuticals Limited is a multinational biopharmaceutical company headquartered in Australia. The company has one commercial pharmaceutical product, SCENESSE โฆSee details»
FAQs - CLINUVEL
CLINUVEL PHARMACEUTICALS LIMITED (ASX: CUV; ADR LEVEL 1: CLVLY; Börse Frankfurt: UR9) is a global specialty pharmaceutical group focused on developing and commercialising โฆSee details»
About Us - Light Skin Science
CLINUVEL pioneered the development of the worldโs first systemic, photoprotective drug and is working to help individuals worldwide who are affected by light. The aim of Light Skin Science โฆSee details»
Home - CLINUVELNews
Dr Grimes, Non-Executive Director at CLINUVEL, discusses the current treatment landscape in the field of vitiligoโincluding the positive progress in regulatory issues and reimbursement of โฆSee details»
CLINUVEL Company Profile - Office Locations, Competitors ... - Craft
Oct 4, 2024 CLINUVEL $88.18 m in annual revenue in FY 2024. See insights on CLINUVEL including office locations, competitors, revenue, financials, executives, subsidiaries and more โฆSee details»
Clinuvel Pharmaceuticals Ltd - Company Profile - GlobalData
Clinuvel Pharmaceuticals Ltd (Clinuvel) is a global specialty pharmaceutical company. The company's primary focus is on the development and commercialization of treatments for โฆSee details»
Clinuvel Pharmaceuticals Ltd Executive & Employee Information
The following section provides information on Clinuvel Pharmaceuticals Ltdโs senior management, executives, CEO and key decision makers and their roles in the organization. For more insight โฆSee details»
Contact - CLINUVEL
Australia (Head Office) Level 22, 535 Bourke Street, Melbourne, Victoria, 3000, Australia. Tel: +61 3 9660 4900 Fax: +61 3 9660 4909 Email: [email protected] United KingdomSee details»
Clinuvel (UK) Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
Please see CLINUVELโs website for the full Forward-Looking Statements disclaimer. Contact:Tel: +61 3 9660 4900Fax: +61 3 9660 4909Email: [email protected] (Head Office), Level โฆSee details»
Clinuvel Pharmaceuticals Ltd Company Profile - GlobalData
Clinuvel Pharmaceuticals Ltd (Clinuvel Pharmaceuticals) is a biopharmaceutical company which focuses on the development of drugs for the treatment of light related severe skin disorders. โฆSee details»
CLINUVEL Communiqué III
In this context, CLINUVEL is in a strong position with good fundamentals โ a strong balance sheet and positive financial and operational performance. As markets adapt to new realities, โฆSee details»